Thrombosis and Haemostasis · 2017 · 28 citations · 44 references
MedicineGeneticsHematologyHemostasisHuman GeneticsProteomicsPlatelet ActivationPlatelet AdhesionPlatelet AggregationPlatelet DisordersPlatelet FunctionPlatelet PhysiologyFrameshift MutationsInherited Platelet DisordersInherited Platelet Function DisordersLiquid Chromatography-mass SpectrometryLiquid Chromatography-mass Spectrometry AnalysisPlatelet Granule SecretionPlatelet Integrin FunctionWashed Platelets
Summary Glanzmann thrombasthenia (GT) is one of the best characterised inherited platelet function disorders but global platelet proteome has not been determined in these patients. We investigated the proteome and function of platelets from two patients with type I GT, caused by different homozygous ITGA2b mutations, from family members and unrelated controls. The global proteome of highly purified washed platelets was quantified by liquid chromatography-mass spectrometry (LC-MS) and targeted MS-methods. Platelet function was analysed by flow cytometry, light transmission aggregometry and flow-based as-says. Platelets from GT patients showed less than 5 % relative levels of the integrin subunit αIIb and 5–9 % fibrinogen compared to controls. These patients demonstrated loss of αIIbβ3-dependent platelet function, but normal platelet granule secretion induced by physiological agonists. Platelets from heterozygous family members of a patient expressed 50–60 % of control αIIb levels which were sufficient for normal αIIbβ3-dependent platelet function. Studying type I GT as model disease we established quantitative LC-MS to detect and clearly distinguish normal platelets, platelets from GT heterozygotes and platelets from GT patients. Diminished levels of factor XIIIB chain, plasminogen and carboxypeptidase 2B were identified in thrombasthenic platelets. Additionally, GT platelets showed up to 2.5-fold increased levels of FcγRIIA and laminin-α4 chain. Elevated levels of platelet FcγRIIA was associated with increased CD63-surface expression after FcγRIIA-crosslinking in one GT-patient which might present a compensatory mechanism of platelet activation in GT. We demonstrate that quantitative LC-MS based proteomics is suitable to validate known but also to identify previously unknown protein level changes of dysfunctional platelets. Supplementary Material to this article is available online at www.thrombosis-online.com.
44
CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
Patrick André, K. S. Srinivasa Prasad, Cécile V. Denis et al. · Nature Medicine · 2002 · 726 citations
Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets
C L Wagner, MA Mascelli, DS Neblock et al. · Blood · 1996 · 435 citations · Full text
Medicine, Biochemistry, Hematology +12